… include p53 peptides, viral vectors, and dendritic cells pulsed … Under cellular stress, p53
becomes activated and stabilized to … p53- and PADRE-peptide–pulsed autologous DCs. Before …

… Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization
in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-…

… neoantigen peptide-pulsed autologous DC vaccine and … The number of mutations in the
TP53 gene ranks at the top, … Eventually, the Neo-DCVac stabilized the patient’s condition …

… and intravenous pulsed dendritic cells in high recurrence risk ovarian … Vaccination with
p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 …

… targets for the development of anticancer vaccines. DC-based anticancer vaccination relies
on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the …

… -tumor effect than the peptide-pulsed DCs, corresponding with … In one trial, small cell lung
cancer patients received p53-… experience suggests that disease stabilization and prolonged …

… vaccines were continued until progressive disease (PD) was determined by immune-related
(… of HLA-A2 or A24 peptide-pulsed α-type-1 polarizing DC vaccines for the treatment of high-…

… Immunotherapy using dendritic cell-based vaccination is a natural approach using the …
outcomes and address the challenges associated with dendritic cell vaccination. Neoantigens are …

… involves the use of tumor vaccines made from autologous or … to electroporate immature
dendritic cells for subsequent co-… disulfide bridge for improved stabilization. When compared to …

… II trial of the p53 peptide cancer vaccine and DC vaccine (16)… response (PR), disease
stabilization, and prolonged survival … -associated antigens used to load dendritic cell vaccines. …